09:15 AM EDT, 03/13/2026 (MT Newswires) -- Health care stocks were rising premarket Friday, with the State Street Health Care Select Sector SPDR ETF ( XLV ) and the iShares Biotechnology ETF (IBB) up 0.3%.

ImmunityBio ( IBRX ) shares were up more than 5% after the company said it has completed manufacturing engineering programs NK2022 and NK2023, establishing a safe and scalable leukapheresis-to-manufacturing pathway for its autologous memory cytokine-enhanced natural killer, or M-ceNK, cell therapy platform.

InMode ( INMD ) stock was up more than 6% after the company said its board approved a new share buyback program for up to roughly 10% of its total outstanding stock, totalling about 6.38 million ordinary shares.

Immutep ( IMMP ) shares were down more than 79% after the company said that an independent data monitoring committee has recommended the discontinuation of a phase 3 trial evaluating eftilagimod alfa as a first line treatment for non-small cell lung cancer.